The Pharma Data

DECEMBER 13, 2020

.–( BUSINESS WIRE )– EdiGene, Inc. which develops genome editing technologies to accelerate drug discovery and develop novel therapeutics for a broad range of diseases, today announced the appointment of Bo Zhang, Ph.D., as Head of Business Development. He received his B.S.

Business Development 40

Business Development Development Gene Editing In-Vivo 40

Drug Discovery World

AUGUST 28, 2023

Could it be possible to prevent genetic diseases? PH: As well as starting clinical trials with our most advanced programme, SAM001, we have two more highly promising programmes that we want to advance to the clinic in the next year or two. DS: What’s next for the company’s pipeline? LinkedIn profile.

Genetics 52

Genetics Protein Genetic Disease Clinical Trials 52

The Pharma Data

DECEMBER 8, 2020

Now poised to advance a robust therapeutics pipeline to clinical development, Nuance will use the funds for ongoing R&D of existing products and business development of potential new assets. The impact of CNS diseases extends beyond patients—to their families and society as well.” Sigilon Therapeutics .

RNA 52

RNA Antibody Life Science Protein 52

The Pharma Data

OCTOBER 15, 2020

The committee is tasked with supporting BeyondSpring’s business development activities related to its lead asset, Plinabulin, and other pipeline assets. Mukul Agarwal, former vice president of Corporate Development, at Forty Seven, Inc., BeyondSpring – BeyondSpring Inc. Sabbagh will replace David Thompson who is retiring.

In-Vivo 52

In-Vivo Business Development Manufacturing Development 52